Skip to main navigation Skip to search Skip to main content

Jan Molenaar

20032026

Research activity per year

Personal profile

Research interests

Onderzoeksbelangen

Fingerprint

Dive into the research topics where Jan Molenaar is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
  • Current treatment strategies for first relapse of high-risk neuroblastoma

    Castelli, S., Schulze, F., Thole-Kliesch, T. M., Astrahantseff, K., Barone, G., Beck-Popovic, M., Berlanga, P., Corbacioglu, S., Fischer, M., Gambart, M., George, S. L., Chesler, L., Gray, J. C., Hero, B., Künkele, A., Flaadt, T., Lang, P., Lode, H. N., Molenaar, J. J. & Schleiermacher, G. & 9 others, Rosswog, C., Moreno, L., Owens, C., Rubio-San-Simón, A., Schulte, J. H., Simon, T., Tweddle, D. A., Deubzer, H. E. & Eggert, A., 11 Mar 2026, In: European Journal of Cancer. 236, 116254.

    Research output: Contribution to journalReview articlepeer-review

    Open Access
    1 Citation (Scopus)
  • Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastoma

    Werr, L., Boland, J., Petersen, J., Iglesias, F., Höppner, S., Bartenhagen, C., Rosswog, C., Hellmann, A. M., Kahlert, Y., Hemstedt, N., Ibruli, N., Dammert, M. A., Decarolis, B., Werner, J. M., Malchers, F., Schramm, K., Witt, O., Beiske, K. H., Rognlien, A. G. W. & Gunnes, M. W. & 27 others, Langenberg, K. P., Molenaar, J., Bernkopf, M., Taschner-Mandl, S., Hughes, D., George, S. L., Chesler, L., Schulte, J. H., Barone, G., Capasso, M., Surrey, L. F., Bagatell, R., Masliah-Planchon, J., Schleiermacher, G., Grüll, H., Westermann, F., Schultheis, A. M., Büttner, R., Henssen, A. G., Eggert, A., Peifer, M., Shukla, N. N., Simon, T., Hero, B., Reinhardt, H. C., Thomas, R. K. & Fischer, M., 1 Apr 2026, In: The Journal of clinical investigation. 136, 7

    Research output: Contribution to journalArticlepeer-review

    Open Access
  • Paediatric Therapeutic Development Workshop on rhabdoid tumours

    Cancer Research UK, Cancer Grand Challenge PROTECT team, On behalf of LifeArc & Innovative Therapies for Children with Cancer (ITCC), 2026, (Accepted/In press) In: British journal of cancer.

    Research output: Contribution to journalReview articlepeer-review

    Open Access
  • Accelerating Drug Development for Neuroblastoma: Consensus Statement From the Third Neuroblastoma Drug Development Strategy Forum

    DuBois, S. G., Moreno, L., Anderson, J., Asgharzadeh, S., Bagatell, R., Beck-Popovic, M., Belle, J., Berlanga, P., Bird, N. J., Chesler, L., Durbin, A., Eggert, A., Eilers, M., Federico, S. M., Fischer, M., Gatz, S. A., George, R. E., George, S., Goldsmith, K. C. & Gray, J. & 25 others, Heczey, A., Irwin, M. S., Knox, L., Lode, H. N., Ludwinski, D., Macy, M. E., Majzner, R. G., Maris, J. M., Modak, S., Molenaar, J. J., Morgenstern, D. A., Mossé, Y. P., Owens, C., Reynolds, C. P., Rossig, C., Schleiermacher, G., Scott, L., Sondel, P. M., Speleman, F., van Noesel, M., Westermann, F., Wienke, J., Wolpaw, A. J., Park, J. R. & Pearson, A. D. J., Sept 2025, In: Pediatric Blood and Cancer. 72, 9, e31831.

    Research output: Contribution to journalReview articlepeer-review

    Open Access
    6 Citations (Scopus)
  • Anti-cancer compound screening identifies Aurora Kinase A inhibition as a means to favor CRISPR/Cas9 gene correction over knock-out

    Wilbie, D., Eising, S., Amo-Addae, V., Walther, J., Bosman, E., Lei, Z., de Jong, O. G., Molenaar, J. J. & Mastrobattista, E., 2025, In: PloS one. 20, 9, p. e0332617

    Research output: Contribution to journalArticlepeer-review

    Open Access